Myomo’s digital transformation strategy integrates advanced technologies across its core operations. The company is actively developing a mobile platform to enhance clinical workflows and patient engagement. Myomo also implements product design changes to standardize customization and improve manufacturing efficiency for its MyoPro devices.
These transformations introduce critical dependencies on robust data systems and integrated workflows. Failures in data synchronization or process adherence can significantly impact patient care, regulatory compliance, and operational scalability. This page analyzes Myomo’s key initiatives, the challenges they create, and where specific sales opportunities exist.
Myomo Snapshot
Headquarters: Burlington, Massachusetts Number of employees: 195 Public or private: Public Business model: Both Website: http://www.myomo.com
Myomo ICP and Buying Roles
Myomo sells to healthcare networks and clinics that provide rehabilitative care. They also sell to government healthcare providers and individual patients.
Who drives buying decisions
- Chief Operating Officer → Oversees operational efficiency and scalability of manufacturing.
- VP of Regulatory Affairs → Manages compliance with medical device regulations and approvals.
- Chief Medical Officer → Guides clinical strategy, patient outcomes, and evidence generation.
- Head of Product Development → Leads innovation and commercialization of new MyoPro features.
- Head of Patient Services → Manages patient onboarding, support programs, and satisfaction.
Key Digital Transformation Initiatives at Myomo (At a Glance)
- Developing a mobile platform for remote device configuration and patient monitoring.
- Standardizing product customization and streamlining the MyoPro fitting process.
- Implementing data analytics to optimize patient acquisition and reimbursement workflows.
- Centralizing clinical trial data collection and analysis for evidence generation.
Where Myomo’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Mobile Health Platform Providers | Mobile Clinical Workflow and Patient Engagement Platform: remote device configuration settings do not consistently sync to MyoPro devices. | Head of Product Development, Chief Medical Officer | Standardize device settings synchronization across mobile and embedded systems. |
| Mobile Clinical Workflow and Patient Engagement Platform: patient usage data fails to integrate with clinical reporting systems. | Chief Operating Officer, Chief Medical Officer | Connect mobile health data streams with existing patient management and reporting platforms. | |
| Mobile Clinical Workflow and Patient Engagement Platform: access to training resources is inconsistent across patient devices. | Head of Patient Services, Head of Product Development | Centralize and distribute training content uniformly to all patient mobile applications. | |
| Product Lifecycle Management (PLM) Software | Product Customization and Manufacturing Standardization: custom design specifications are not consistently applied during device fabrication. | Head of Manufacturing, VP of Regulatory Affairs | Enforce consistent application of custom design rules throughout the fabrication process. |
| Product Customization and Manufacturing Standardization: updated training documentation does not reach all certified clinicians promptly. | Chief Operating Officer, Head of Product Development | Distribute critical product updates and training materials to certified partners immediately. | |
| Product Customization and Manufacturing Standardization: user feedback from new product versions does not integrate into the design iteration process. | Head of Product Development | Route user experience data from new product versions directly into the design feedback loop. | |
| Healthcare Revenue Cycle Management (RCM) Platforms | Data-Driven Patient Journey and Reimbursement Management: patient eligibility verification creates delays in the billing system. | Chief Financial Officer, Head of Patient Services | Automate real-time patient eligibility checks against payer databases. |
| Data-Driven Patient Journey and Reimbursement Management: referral tracking data does not accurately attribute patient sources in the CRM. | Head of Patient Services, VP of Sales and Marketing | Standardize referral data capture and integration within the customer relationship management system. | |
| Data-Driven Patient Journey and Reimbursement Management: Medicare Part B claim submissions frequently require manual correction. | Chief Financial Officer, VP of Regulatory Affairs | Validate claim data against Medicare Part B requirements before submission. | |
| Clinical Trial Management Systems (CTMS) | Clinical Research Data Management Systems: clinical data from trial sites fails to centralize for analysis. | Chief Medical Officer, Head of Research and Development | Consolidate disparate clinical data sources into a unified research database. |
| Clinical Research Data Management Systems: regulatory submission documents contain inconsistent clinical trial results. | VP of Regulatory Affairs, Chief Medical Officer | Enforce data consistency checks across all clinical research outputs before regulatory filings. | |
| Clinical Research Data Management Systems: consent form tracking for clinical participants involves manual record keeping. | Head of Research and Development | Automate the digital tracking and archiving of all clinical trial consent forms. |
Identify when companies like Myomo are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Myomo’s digital transformation unique
Myomo’s digital transformation prioritizes patient-centricity within a highly regulated medical device environment. They depend heavily on integrating precise electromyography (EMG) signal data with custom device fabrication systems to deliver personalized orthoses. This makes their transformation complex, as it must balance agile product development with stringent regulatory compliance and individual patient needs. Their focus on mobile patient engagement and data-driven reimbursement reflects a unique challenge in a market shifting towards long-term home care.
Myomo’s Digital Transformation: Operational Breakdown
DT Initiative 1: Mobile Clinical Workflow and Patient Engagement Platform
What the company is doing
Myomo is building a mobile application for clinicians to customize MyoPro device settings. This platform also allows patients to monitor their muscle activity and access training materials directly. The system aims to provide real-time insights into device usage and patient progress.
Who owns this
- Head of Product Development
- Chief Medical Officer
- Head of Patient Services
Where It Fails
- Remote EMG setting adjustments in the mobile application do not consistently apply to MyoPro devices.
- Patient usage data from the mobile platform does not automatically populate into existing electronic health record (EHR) systems.
- Updates to training content within the mobile app do not instantly propagate to all patient devices.
- Device performance analytics from the mobile infrastructure contain incomplete data points.
Talk track
Noticed Myomo is expanding its mobile clinical platform. Been looking at how some medical device companies are ensuring device settings synchronize perfectly across all platforms, can share what’s working if useful.
DT Initiative 2: Product Customization and Manufacturing Standardization
What the company is doing
Myomo introduces standardized customizations within its MyoPro 2x device to streamline fitting for clinicians. This initiative involves integrating common design modifications directly into the manufacturing process. The company also updates training documentation to support quicker and more consistent device setup.
Who owns this
- Head of Manufacturing
- Head of Product Development
- VP of Regulatory Affairs
Where It Fails
- Customized components generated in CAD systems do not always match the physical output during 3D printing.
- New product iteration data from engineering design platforms does not automatically update manufacturing templates.
- Changes to design specifications in the PLM system do not trigger automatic revision of related training manuals.
- Supplier specifications for raw materials do not consistently align with new standardized design requirements.
Talk track
Looks like Myomo is standardizing product customization for MyoPro devices. Been seeing how some manufacturers are automating the transfer of design changes directly to their fabrication systems, happy to share what we’re seeing.
DT Initiative 3: Data-Driven Patient Journey and Reimbursement Management
What the company is doing
Myomo focuses on leveraging patient data to enhance acquisition strategies and streamline reimbursement processes. The company specifically targets recurring patient sources and optimizes operations around Medicare Part B coverage. Myomo's MyoConnect program supports patient referrals and optimizes revenue.
Who owns this
- Chief Financial Officer
- Head of Patient Services
- VP of Sales and Marketing
Where It Fails
- Patient demographic data in the CRM does not consistently match information in the billing system for reimbursement.
- Referral tracking codes from the MyoConnect program do not accurately populate into lead generation dashboards.
- Changes in payer policy documentation are not immediately reflected in the claims processing rules engine.
- Cost per patient acquisition metrics in the marketing analytics platform show discrepancies with actual financial reporting.
Talk track
Saw Myomo is optimizing its data-driven patient journey and reimbursement. Been looking at how some healthcare providers are ensuring seamless data flow between CRM and billing systems for accurate claim submissions, can share what’s working if useful.
DT Initiative 4: Clinical Research Data Management Systems
What the company is doing
Myomo manages and analyzes data from its ongoing clinical trials and studies. This system supports the generation of evidence for MyoPro device efficacy. The company also uses this data to support regulatory submissions and expand market access.
Who owns this
- Chief Medical Officer
- Head of Research and Development
- VP of Regulatory Affairs
Where It Fails
- Clinical data from multiple research sites enters the central database with inconsistent formatting.
- Patient consent form records stored in the document management system do not automatically link to individual patient data sets.
- Regulatory audit trails for data integrity cannot be generated consistently across all study phases.
- Statistical analysis reports contain data points that contradict source clinical observations.
Talk track
Seems like Myomo is enhancing its clinical research data management systems. Been seeing how some biotech companies are standardizing data input protocols across all research sites to prevent inconsistencies, happy to share what we’re seeing.
Who Should Target Myomo Right Now
This account is relevant for:
- Mobile health application development platforms
- Product lifecycle management (PLM) software vendors
- Healthcare revenue cycle management (RCM) platforms
- Clinical trial management system (CTMS) providers
- Data quality and integration platforms
- Regulatory compliance management software
Not a fit for:
- Generic ERP system providers without medical device specialization
- Basic marketing automation tools
- Stand-alone HR software solutions
- Consumer-facing wellness apps
When Myomo Is Worth Prioritizing
Prioritize if:
- You sell mobile device management solutions for secure application deployment and configuration.
- You sell PLM software that automates the transfer of design changes to manufacturing workflows.
- You sell RCM platforms that integrate patient eligibility and referral data with billing systems.
- You sell CTMS platforms that centralize and standardize clinical trial data from multiple sources.
- You sell data integration platforms that ensure consistent data flow between disparate healthcare systems.
Deprioritize if:
- Your solution does not address any of the breakdowns above.
- Your product is limited to basic functionality with no integration capabilities for medical devices.
- Your offering is not built for multi-team or highly regulated environments.
Who Can Sell to Myomo Right Now
Mobile Health Platform Providers
Veeva Systems - This company offers cloud-based software for the global life sciences industry, including clinical, regulatory, quality, and commercial solutions.
Why they are relevant: Myomo's mobile clinical workflow platform experiences inconsistent data sync between devices and clinical systems. Veeva's mobile and patient engagement solutions can ensure secure, compliant, and consistent data capture and synchronization, preventing patient usage data from being siloed.
Aptible - This company provides a compliance and security platform for healthcare applications.
Why they are relevant: Myomo's new mobile app for patient engagement collects sensitive health data. Aptible can help Myomo maintain HIPAA compliance and secure its mobile digital infrastructure, preventing data security breaches and regulatory non-compliance.
Product Lifecycle Management (PLM) Software
Arena Solutions (PTC) - This company provides cloud-native product lifecycle management (PLM) software for product realization.
Why they are relevant: Myomo’s product customization process for MyoPro devices faces inconsistencies between design specifications and manufacturing output. Arena Solutions can enforce precise design control and revision management, ensuring that manufacturing templates reflect the latest product design data accurately and consistently.
Propel Software - This company delivers product lifecycle management (PLM) and quality management solutions built on Salesforce.
Why they are relevant: Myomo needs to integrate user feedback from MyoPro 2x into future design iterations. Propel can connect customer feedback directly into the PLM system, ensuring that product development workflows quickly adapt to market needs and clinician input.
Healthcare Revenue Cycle Management (RCM) Platforms
Waystar - This company offers a platform that simplifies healthcare payments by streamlining workflows across the revenue cycle.
Why they are relevant: Myomo experiences delays in billing due to inconsistent patient eligibility verification and manual claim corrections. Waystar can automate eligibility checks and pre-submission claim validation, preventing payment denials and accelerating revenue recognition by reducing manual intervention.
Navigating Healthcare - This company provides software solutions for patient engagement and referral management in healthcare.
Why they are relevant: Myomo's MyoConnect program needs accurate attribution of patient sources. Navigating Healthcare can track and integrate referral data into Myomo’s CRM, ensuring that patient acquisition channels are properly identified and optimized.
Clinical Trial Management Systems (CTMS)
Medidata Solutions (Dassault Systèmes) - This company provides cloud-based solutions for clinical development, including study design, execution, and data management.
Why they are relevant: Myomo's clinical research data management systems struggle with inconsistent data formatting from various trial sites. Medidata can standardize data input protocols and centralize data collection, ensuring high-quality, analyzable data for evidence generation and regulatory submissions.
Florence Healthcare - This company offers an electronic document management system for clinical trials.
Why they are relevant: Myomo's clinical trials involve manual tracking of patient consent forms and regulatory audit trails. Florence Healthcare can digitize and automate the management of trial documents, ensuring compliance and easy retrieval for audits.
Final Take
Myomo is scaling its MyoPro product line and patient engagement through focused digital transformation initiatives. Breakdowns are visible in data synchronization between mobile platforms and clinical systems, inconsistencies in product customization, and manual efforts in patient reimbursement and clinical data management. This account is a strong fit for vendors offering specialized solutions that automate data integrity, standardize complex workflows, and ensure regulatory compliance within the medical device sector.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.